Literature DB >> 28125151

Pleuroparenchymal fibroelastosis: report of two cases in Brazil.

Paula Silva Gomes1, Christina Shiang2, Gilberto Szarf3, Ester Nei Aparecida Martins Coletta4,5, Carlos Alberto de Castro Pereira6.   

Abstract

Pleuroparenchymal fibroelastosis (PPFE) is a rare lung disease. It can be idiopathic or associated with any one of various conditions. To our knowledge, this is the first report of two cases of PPFE in Brazil. Our first patient presented with pleural and subpleural fibrosis in the upper lobes; a spiculated nodule in the left upper lobe; and a mild reticular pattern in the lower lobes. Surgical lung biopsy revealed PPFE in the upper lobes, including the nodule, and unclassified interstitial pneumonia in the left lower lobe. Our second patient had a history of exposure to domestic birds, indicating a risk of hypersensitivity pneumonitis, and presented with advanced lung disease, predominantly in the upper lobes, together with subpleural fibrosis.That patient underwent lung transplantation. In the explant specimen, PPFE and granulomas were identified, suggesting hypersensitivity pneumonitis as an associated cause. RESUMO A fibroelastose pleuroparenquimatosa (FEPP) é uma doença pulmonar rara, podendo ser idiopática ou associada a diversas condições. Pelo que sabemos, este é o primeiro relato de dois casos de FEPP no Brasil. Nosso primeiro paciente apresentava fibrose pleural e subpleural nos lobos superiores, um nódulo espiculado no lobo superior esquerdo e um padrão reticular discreto nos lobos inferiores. A biópsia pulmonar cirúrgica demonstrou FEPP nos lobos superiores, incluindo no nódulo, e pneumonia intersticial não classificada no lobo inferior esquerdo. Nosso segundo paciente tinha história de exposição a aves domésticas, indicando um risco de pneumonite de hipersensibilidade, e doença pulmonar avançada predominando em lobos superiores, com fibrose subpleural. Esse paciente foi submetido a transplante pulmonar. No espécime do explante, FEPP e granulomas foram identificados, sugerindo pneumonite de hipersensibilidade como causa associada.

Entities:  

Mesh:

Year:  2017        PMID: 28125151      PMCID: PMC5790665          DOI: 10.1590/S1806-37562016000000045

Source DB:  PubMed          Journal:  J Bras Pneumol        ISSN: 1806-3713            Impact factor:   2.624


  16 in total

1.  Distinct characteristics of pleuroparenchymal fibroelastosis with usual interstitial pneumonia compared with idiopathic pulmonary fibrosis.

Authors:  Tsuneyuki Oda; Takashi Ogura; Hideya Kitamura; Eri Hagiwara; Tomohisa Baba; Yasunori Enomoto; Tae Iwasawa; Koji Okudela; Tamiko Takemura; Fumikazu Sakai; Yoshinori Hasegawa
Journal:  Chest       Date:  2014-11       Impact factor: 9.410

2.  Lung transplantation for pleuroparenchymal fibroelastosis after chemotherapy.

Authors:  Fengshi Chen; Kousaku Matsubara; Aya Miyagawa-Hayashino; Kimihide Tada; Tomohiro Handa; Tetsu Yamada; Masaaki Sato; Akihiro Aoyama; Hiroshi Date
Journal:  Ann Thorac Surg       Date:  2014-10-30       Impact factor: 4.330

3.  Pleuroparenchymal fibroelastosis from a consecutive database: a rare disease entity?

Authors:  Takeshi Nakatani; Toru Arai; Masanori Kitaichi; Masanori Akira; Kazunobu Tachibana; Chikatoshi Sugimoto; Aya Hirooka; Taisuke Tsuji; Shojiro Minomo; Seiji Hayashi; Yoshikazu Inoue
Journal:  Eur Respir J       Date:  2015-02-19       Impact factor: 16.671

4.  Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes.

Authors:  Taryn L Reddy; Masaki Tominaga; David M Hansell; Jan von der Thusen; Doris Rassl; Helen Parfrey; Suzy Guy; Orion Twentyman; Alexandra Rice; Toby M Maher; Elisabetta A Renzoni; Athol U Wells; Andrew G Nicholson
Journal:  Eur Respir J       Date:  2012-03-22       Impact factor: 16.671

5.  Pleuroparenchymal fibroelastosis as a manifestation of chronic lung rejection?

Authors:  Takako Hirota; Masaki Fujita; Takemasa Matsumoto; Takao Higuchi; Takeshi Shiraishi; Masato Minami; Meinoshin Okumura; Kazuki Nabeshima; Kentaro Watanabe
Journal:  Eur Respir J       Date:  2013-01       Impact factor: 16.671

6.  Pleuroparenchymal fibroelastosis: one more walk on the wild side of drugs?

Authors:  Philippe Camus; Jan von der Thüsen; David M Hansell; Thomas V Colby
Journal:  Eur Respir J       Date:  2014-08       Impact factor: 16.671

7.  Pleuroparenchymal fibroelastosis in association with carcinomas.

Authors:  Eva Baroke; Claus Peter Heussel; Arne Warth; Monika Eichinger; Ute Oltmanns; Karin Palmowski; Felix J F Herth; Michael Kreuter
Journal:  Respirology       Date:  2015-10-13       Impact factor: 6.424

8.  Pleuroparenchymal fibroelastosis presenting as a hypermetabolic lung nodule.

Authors:  Jenny S Machuca; Masooma Niazi; Gilda Diaz-Fuentes
Journal:  J Bronchology Interv Pulmonol       Date:  2011-01

9.  Pleuroparenchymal fibroelastosis in patients with pulmonary disease secondary to bone marrow transplantation.

Authors:  Jan H von der Thüsen; David M Hansell; Masaki Tominaga; Paul A Veys; Michael T Ashworth; Catherine M Owens; Andrew G Nicholson
Journal:  Mod Pathol       Date:  2011-08-05       Impact factor: 7.842

10.  Idiopathic pleuroparenchymatous fibroelastosis: A case report and brief review of the literature.

Authors:  Kristof Cuppens; Eric Verbeken; Johan Coolen; Johny Verschakelen; Wim Wuyts
Journal:  Respir Med Case Rep       Date:  2014-03-14
View more
  1 in total

1.  Idiopathic pulmonary fibrosis in Brazil: challenges for epidemiological characterization and management.

Authors:  Bruno Guedes Baldi
Journal:  J Bras Pneumol       Date:  2017 Nov-Dec       Impact factor: 2.624

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.